NM_000404.4:c.622C>T

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS3PM1PP2PP3_ModeratePP5_Very_Strong

The NM_000404.4(GLB1):​c.622C>T​(p.Arg208Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000254 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001751808: Published functional studies demonstrate that the R208C variant abolishes the catalytic activity of the -galactosidase enzyme (Boustany et al., 1993)" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R208H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

GLB1
NM_000404.4 missense

Scores

10
5
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:12O:1

Conservation

PhyloP100: 5.24

Publications

20 publications found
Variant links:
Genes affected
GLB1 (HGNC:4298): (galactosidase beta 1) This gene encodes a member of the glycosyl hydrolase 35 family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature lysosomal enzyme. This enzyme catalyzes the hydrolysis of a terminal beta-linked galactose residue from ganglioside substrates and other glycoconjugates. Mutations in this gene may result in GM1-gangliosidosis and Morquio B syndrome. [provided by RefSeq, Nov 2015]
GLB1 Gene-Disease associations (from GenCC):
  • GM1 gangliosidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • GM1 gangliosidosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • mucopolysaccharidosis type 4B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • GM1 gangliosidosis type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • GM1 gangliosidosis type 2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV001751808: Published functional studies demonstrate that the R208C variant abolishes the catalytic activity of the -galactosidase enzyme (Boustany et al., 1993);; SCV000754699: Experimental studies have shown that this missense change affects GLB1 function (PMID: 8213816, 15714521, 23337983).; SCV003696359: "In vitro studies demonstrated that this variant abolished catalytic activity of the beta-galactosidase protein in transfected COS-1 cells (Boustany, 1993)."
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000404.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 110 curated pathogenic missense variants (we use a threshold of 10). The gene has 24 curated benign missense variants. Gene score misZ: 0.79419 (below the threshold of 3.09). Trascript score misZ: 1.1264 (below the threshold of 3.09). GenCC associations: The gene is linked to mucopolysaccharidosis type 4B, GM1 gangliosidosis, GM1 gangliosidosis type 3, GM1 gangliosidosis type 2, GM1 gangliosidosis type 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.905
PP5
Variant 3-33058200-G-A is Pathogenic according to our data. Variant chr3-33058200-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000404.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLB1
NM_000404.4
MANE Select
c.622C>Tp.Arg208Cys
missense
Exon 6 of 16NP_000395.3
GLB1
NM_001317040.2
c.766C>Tp.Arg256Cys
missense
Exon 7 of 17NP_001303969.2
GLB1
NM_001079811.3
c.532C>Tp.Arg178Cys
missense
Exon 6 of 16NP_001073279.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLB1
ENST00000307363.10
TSL:1 MANE Select
c.622C>Tp.Arg208Cys
missense
Exon 6 of 16ENSP00000306920.4P16278
GLB1
ENST00000307377.12
TSL:1
c.341-4651C>T
intron
N/AENSP00000305920.8E7EQ29
GLB1
ENST00000399402.7
TSL:2
c.532C>Tp.Arg178Cys
missense
Exon 6 of 16ENSP00000382333.2P16278

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152106
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000917
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000442
AC:
11
AN:
249146
AF XY:
0.0000518
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.0000144
AC:
21
AN:
1461862
Hom.:
0
Cov.:
32
AF XY:
0.00000963
AC XY:
7
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33478
American (AMR)
AF:
0.0000671
AC:
3
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000989
AC:
11
AN:
1111998
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152224
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41552
American (AMR)
AF:
0.000916
AC:
14
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68000
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000512
Hom.:
0
Bravo
AF:
0.000151
ExAC
AF:
0.0000579
AC:
7

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
not provided (3)
2
-
-
Infantile GM1 gangliosidosis (2)
1
-
-
GM1 gangliosidosis (2)
1
-
-
GM1 gangliosidosis type 2 (1)
1
-
-
GM1 gangliosidosis type 3 (1)
1
-
-
GM1 gangliosidosis;C0086652:Mucopolysaccharidosis, MPS-IV-B (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
Mucopolysaccharidosis, MPS-IV-B (1)
1
-
-
Mucopolysaccharidosis, MPS-IV-B;C0268271:Infantile GM1 gangliosidosis;C0268272:GM1 gangliosidosis type 2;C0268273:GM1 gangliosidosis type 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.36
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.81
D
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.90
D
MetaSVM
Pathogenic
1.1
D
PhyloP100
5.2
PrimateAI
Benign
0.26
T
PROVEAN
Pathogenic
-6.4
D
REVEL
Pathogenic
0.85
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0060
D
Vest4
0.57
MVP
0.98
MPC
0.94
ClinPred
0.96
D
GERP RS
4.7
gMVP
0.83
Mutation Taster
=7/93
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72555366; hg19: chr3-33099692; COSMIC: COSV56565439; COSMIC: COSV56565439; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.